Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy Participants

Clinical trial NCT07646548 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07646548
Sponsor: Sanofi
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2026-06-11
Primary completion: 2026-09-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.